Safety Profile of Nivolumab in Japanese NSCLC Pts: Interim Results from Post-marketing All-Case Surveillance in Japan

被引：0
|
作者：
Genma, Akihiko [1 ]
Nakanishi, Yoichi [2 ]
Nakagawa, Kazuhiko [3 ]
Yamamoto, Nobuyuki [4 ]
Saito, Takeshi [5 ]
Tahara, Yasuhiro [5 ]
Ohe, Yuichiro [6 ]
机构：
[1] Nippon Med Sch, Tokyo, Japan
[2] Kyushu Univ, Sch Med, Fukuoka, Japan
[3] Kindai Univ, Sch Fac Med, Higashiosaka, Osaka, Japan
[4] Wakayama Med Univ, Wakayama, Japan
[5] Ono Pharmaceut CO LTD, Osaka, Japan
[6] Natl Canc Ctr, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SPS-9
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [41] Post-Marketing Surveillance of Tofacitinib in Japanese Patients with Rheumatoid Arthritis: An Interim Report of Safety Data
    Mimori, Tsuneyo
    Harigai, Masayoshi
    Atsumi, Tatsuya
    Kuwana, Masataka
    Takei, Syuji
    Tamura, Naoto
    Fujii, Takao
    Matsuno, Hiroaki
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Kokubo, Takeshi
    Endo, Yutaka
    Sugiyama, Naonobu
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [42] POST-MARKETING SURVEILLANCE OF TOFACITINIB IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM REPORT OF SAFETY DATA
    Mimori, T.
    Harigai, M.
    Atsumi, T.
    Kuwana, M.
    Takei, S.
    Tamura, N.
    Fuji, T.
    Matsuno, H.
    Momohara, S.
    Yamamoto, K.
    Kokubo, T.
    Endo, Y.
    Sugiyama, N.
    Hirose, T.
    Morishima, Y.
    Yoshii, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1200 - 1201
  • [43] Fluvoxamine: Safety profile in extensive post-marketing surveillance
    Buchberger, R
    Wagner, W
    [J]. PHARMACOPSYCHIATRY, 2002, 35 (03) : 101 - 108
  • [44] Correction to: Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan
    Shunji Takahashi
    Makoto Tahara
    Koichi Ito
    Masayuki Tori
    Naomi Kiyota
    Katsutoshi Yoshida
    Yukinori Sakata
    Akira Yoshida
    [J]. Advances in Therapy, 2021, 38 : 4989 - 4993
  • [45] Safety of Baricitinib Under Clinical Settings in Patients with Rheumatoid Arthritis, Using Data from All-Case Post-marketing Surveillance and Spontaneous Reports
    Matsuno, Hiroaki
    Atsumi, Tatsuya
    Takei, Shuji
    Tamura, Naoto
    Harigai, Masayoshi
    Fujii, Takao
    Momohara, Shigeki
    Takahashi, Yuko
    Narii, Nobuhiro
    Tsujimoto, Naoto
    Nishikawa, Atsushi
    Ishii, Taeko
    Yamamoto, Kazuhiko
    Kuwana, Masataka
    Takagi, Michiaki
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [46] Safety and effectiveness of nusinersen, a treatment for spinal muscular atrophy, in 524 patients: results from an interim analysis of post-marketing surveillance in Japan
    Tachibana, Yosuke
    Sato, Ryusuke
    Makioka, Haruki
    Hoshino, Misuzu
    Jin, Mingshou
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2023,
  • [47] Real-world anamorelin use in 4,672 patients with cancer cachexia; Results from post-marketing all-case surveillance
    Muro, Kei
    Nakayama, Masahiro
    Honda, Chikara
    Machii, Koji
    Endo, Toshimitsu
    Takayama, Koichi
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1387 - S1388
  • [48] Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan
    Kimata, Masahiro
    Watanabe, Asuka
    Yanagida, Yukiko
    Kinoshita, Daisuke
    Maekawa, Shinichiroh
    [J]. INFECTIOUS DISEASES AND THERAPY, 2023, 12 (04) : 1119 - 1136
  • [49] Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan
    Masahiro Kimata
    Asuka Watanabe
    Yukiko Yanagida
    Daisuke Kinoshita
    Shinichiroh Maekawa
    [J]. Infectious Diseases and Therapy, 2023, 12 : 1119 - 1136
  • [50] Patient profile with ATTR-FAP and evaluation of the safety and efficacy of tafamidis meglumine in Japan - interim analysis in post-marketing surveillance
    Ishii, Tomonori
    Sekijima, Yoshiki
    Ando, Yukio
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 : 45 - 46
12345